Dec 31, 2023
NCT06158841: Phase 3: Intravenous (IV) ABBV-383 Monotherapy Versus Standard Therapies Relapsed/Refractory Myeloma
NCT06158841: Phase 3: Intravenous (IV) ABBV-383 Monotherapy Versus Standard Therapies RRMM Study Assessing Activity of Intravenous (IV)...
165
Dec 1, 2023
Myeloma UK Publication, intended for UK Audience: Myeloma – An Introduction - Myeloma Essentials
Myeloma UK Publication, intended for UK Audience Myeloma – An Introduction - Myeloma Essentials https://www.myeloma.org.uk/...
178
Dec 1, 2023
NCCN GUIDELINES FOR PATIENTS: MULTIPLE MYELOMA 2023
NCCN GUIDELINES FOR PATIENTS: MULTIPLE MYELOMA 2023 Click here to see patient's guideline book by NCCN. Presented with support from: NCCN...
418
Dec 1, 2023
What is Multiple Myeloma? www.uptodate.com
www.uptodate.com - What is Multiple Myeloma? Patient education: Multiple myeloma symptoms, diagnosis, and staging (Beyond the Basics)...
270
Dec 1, 2023
Explore MCT: Join us in creating the most comprehensive platform for Myeloma Clinical Trials
How to Navigate through MCT Website and find high yield topics. You can also search any topic in search bar to find related posts....
404
Dec 16, 2022
Patient Education: Daratumumab & Daratumumab and Hyaluronidase-fihj - Monoclonal Ab - Immunotherapy
Patient Education: Daratumumab & Daratumumab and Hyaluronidase-fihj DARATUMUMAB (DARZALEX) NIH National cancer institute - cancer.gov...
528